Consequences of In Utero Caffeine Exposure on Respiratory Output in Normoxic and Hypoxic Conditions and Related Changes of Fos Expression: A Study on Brainstem-Spinal Cord Preparations Isolated From Newborn Rats
Abstract:Several aspects of the central regulation of respiratory control have been investigated on brainstem-spinal cord preparations isolated from newborn rats whose dam was given 0.02% caffeine in water as drinking fluid during the whole period of pregnancy. Analysis of the central respiratory drive estimated by the recording of C4 ventral root activity was correlated to Fos pontomedullary expression. Under normoxic conditions, preparations obtained from the caffeine-treated group of animals displayed a higher respi… Show more
“…Gressens et al (2001) have documented caffeine-induced acceleration of the evagination of neuroepithelium into telencephalic vesicles (Sahir et al, 2000) and upregulation of sonic hedgehog (Sahir et al, 2004). Gestational caffeine also downregulates central adenosine receptors (Leon et al, 2005;Lorenzo et al, 2010), reduces NMDA antagonist-induced locomotor activity (da Silva et al, 2005), and affects respiratory control (Bodineau et al, 2003;Saadani-Makki et al, 2004). Cognitive and motor deficits have also been reported in adult rodents exposed in caffeine during gestation and/or early postnatal life (Bjorklund et al, 2008;Soellner et al, 2009), although some impairments may be paradigm specific (Soellner et al, 2009).…”
Most drugs of abuse easily cross the placenta and can affect fetal brain development. In utero exposures to drugs thus can have long-lasting implications for brain structure and function. These effects on the developing nervous system, before homeostatic regulatory mechanisms are properly calibrated, often differ from their effects on mature systems. In this review, we describe current knowledge on how alcohol, nicotine, cocaine, amphetamine, Ecstasy, and opiates (among other drugs) produce alterations in neurodevelopmental trajectory. We focus both on animal models and available clinical and imaging data from cross-sectional and longitudinal human studies. Early studies of fetal exposures focused on classic teratological methods that are insufficient for revealing more subtle effects that are nevertheless very behaviorally relevant. Modern mechanistic approaches have informed us greatly as to how to potentially ameliorate the induced deficits in brain formation and function, but conclude that better delineation of sensitive periods, dose-response relationships, and long-term longitudinal studies assessing future risk of offspring to exhibit learning disabilities, mental health disorders, and limited neural adaptations are crucial to limit the societal impact of these exposures.
“…Gressens et al (2001) have documented caffeine-induced acceleration of the evagination of neuroepithelium into telencephalic vesicles (Sahir et al, 2000) and upregulation of sonic hedgehog (Sahir et al, 2004). Gestational caffeine also downregulates central adenosine receptors (Leon et al, 2005;Lorenzo et al, 2010), reduces NMDA antagonist-induced locomotor activity (da Silva et al, 2005), and affects respiratory control (Bodineau et al, 2003;Saadani-Makki et al, 2004). Cognitive and motor deficits have also been reported in adult rodents exposed in caffeine during gestation and/or early postnatal life (Bjorklund et al, 2008;Soellner et al, 2009), although some impairments may be paradigm specific (Soellner et al, 2009).…”
Most drugs of abuse easily cross the placenta and can affect fetal brain development. In utero exposures to drugs thus can have long-lasting implications for brain structure and function. These effects on the developing nervous system, before homeostatic regulatory mechanisms are properly calibrated, often differ from their effects on mature systems. In this review, we describe current knowledge on how alcohol, nicotine, cocaine, amphetamine, Ecstasy, and opiates (among other drugs) produce alterations in neurodevelopmental trajectory. We focus both on animal models and available clinical and imaging data from cross-sectional and longitudinal human studies. Early studies of fetal exposures focused on classic teratological methods that are insufficient for revealing more subtle effects that are nevertheless very behaviorally relevant. Modern mechanistic approaches have informed us greatly as to how to potentially ameliorate the induced deficits in brain formation and function, but conclude that better delineation of sensitive periods, dose-response relationships, and long-term longitudinal studies assessing future risk of offspring to exhibit learning disabilities, mental health disorders, and limited neural adaptations are crucial to limit the societal impact of these exposures.
“…22 Under conditions of normoxia, animals treated with caffeine presented higher breathing frequency than a control group, and under conditions of hypoxia, the resulting respiratory depression was emphasized by intrauterine exposure to caffeine. 22,23 Such data are in agreement with the tachypnea found in neonates of women who reported an important consumption of caffeine during pregnancy.…”
Section: Mcculloch Et Al Quantified Caffeine In Umbilical Bloodmentioning
confidence: 96%
“…22 Under conditions of normoxia, animals treated with caffeine presented higher breathing frequency than a control group, and under conditions of hypoxia, the resulting respiratory depression was emphasized by intrauterine exposure to caffeine. 22,23 Such data are in agreement with the tachypnea found in neonates of women who reported an important consumption of caffeine during pregnancy. 24 Preterm infants with birth weight of 500 to 1,250 g treated with caffeine during the first 10 days have a reduced rate of bronchopulmonary dysplasia, and present a better neurodevelopmental outcome at 18 to 21 months than a control group.…”
Section: Mcculloch Et Al Quantified Caffeine In Umbilical Bloodmentioning
Objective: To determine the influence of presence of caffeine in umbilical cord blood on apnea occurrence.
Methods:A prospective cohort study with preterm newborns with birth weight lower than 2,000 g was undertaken. Exclusion criteria were: mothers who received opioids; mechanical ventilation during the first 4 days of life; cerebral and major cardiac malformations; perinatal asphyxia; severe periintraventricular hemorrhage; exchange transfusion before the fourth day of life; and those who received methylxantine prior to extubation. Neonates were divided into detectable and undetectable caffeine in umbilical cord blood. Newborns were followed for the first 4 days for occurrence of apnea spells.Results: Eighty-seven newborns with and 40 without detectable caffeine in umbilical cord blood were studied. Median caffeine concentration of the 87 patients with detectable caffeine in umbilical blood was 2.3 µg/mL (0.2-9.4 µg/mL). There was no association between occurrence of apnea spells and presence of caffeine in umbilical cord blood. Neonates with detectable caffeine in umbilical blood had borderline later apnea (66.3±4.14 hours) than those with undetectable levels (54.2±6.26 hours).
Conclusion:Detected levels of caffeine in umbilical cord blood did not decrease occurrence of apnea of prematurity, but it had a borderline effect delaying its occurrence, suggesting that even a low level of caffeine in umbilical cord blood might delay occurrence of apnea spells.J Pediatr (Rio J). 2010;86(2):137-142: Prematurity, apnea, caffeine, low-birth-weight infant.
“…Hence, this analysis has allowed a positive correlation between the alterations in RF and changed neuronal activity in both the medial parabrachial nucleus and the ventrolateral reticular neurons to be found. In addition, the analysis of consequences of in utero caffeine exposure on respiratory output based on C4 ventral root activity and its correlation with c-fos expression has also been extended to normoxic and hypoxic conditions (Bodineau et al 2003). Interestingly, in rats ponto-medullary respiratory disturbances caused by in utero caffeine exposure can be prevented by the presence of caffeine in the milk ).…”
This review discusses epidemiology and laboratory studies on the effects of prenatal methylxanthine administration on some systems developing organisms. They are mainly absorbed from coffee, tea and cocoa products such as cola beverages and chocolate bars.Prenatal methylxanthine exposure can induce several unfavourables changes in the developing organism, which are persistent even in later phases of life. Based on results obtained from animal studies, the effect on embryogenesis is not only poorly understood but also controversial. It is therefore important to study interspecies differences as results may differ depending on animals used and administration methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.